Intramuscular Injection of Sotagliflozin Promotes Neovascularization in Diabetic Mice through Enhancing Skeletal Muscle Cells Paracrine Function

Researchers investigated whether sotagliflozin, an anti-hyperglycemia SGLT2 inhibitor, exerted therapeutic angiogenesis effects in diabetic HLI in vitro and in vivo.